A synthesis of biology, data science and sociology — aided by artificial intelligence — is creating a pipeline of innovative treatments
Japanese pharma group takes on new jab that makes immune system attack dangerous protein build-up in brain
Military activity blamed for surge in jamming and spoofing incidents affecting smartphones, planes and ships
Drugmaker follows Eli Lilly in cutting out middlemen and selling directly to patients
Agreement worth up to $1.2bn includes plan for combined flu and Covid shots
Also in this newsletter: Carmakers shift focus to hybrids, the return to the pub, science round-up
Latest data from UK Health Security Agency shows jump in cases in first three months of the year
The technology can do wonderful things — but its achievements should not come at the expense of basic protections
AlphaFold 3 aims to reveal biological secrets and boost drug search efforts
Anglo-Swedish drugmaker says availability of newer vaccines hit demand for jab
Geologists are exploring whether magmatic brine can be tapped for dissolved treasure such as lithium, copper and cobalt
Food and Drug Administration poised to call for outside assessment of Lykos PTSD therapy in test for psychedelics sector
Weight-loss treatments are not the only source of excitement in the pharmaceutical research world
Novo Nordisk, Bill & Melinda Gates Foundation and Wellcome focus on interlinked issues
Experts warn better data is required to drive policy as debilitating condition reduces workforce
Shadow science minister Chi Onwurah pledges more collaborative approach and greater respect for institutions
Also in this newsletter: ‘seismic’ by-election results for Labour, and G7 at odds over Russia’s frozen assets
While pandemic risk is low, scientists say urgent investigations into the virus are necessary
For stretched public health budgets, high-tech treatments are hard to afford but some pre-emptive measures can prove good value
Caseloads of cancer and other illnesses of ageing are forecast to rise steeply in lower income countries
Wellcome’s John-Arne Røttingen says divisions risk harming action on pandemic responses and ‘superbugs’
‘Sea sparkle’ bedazzles in the dark but is responsible for a reeking green carpet of algae by day
Now is not a time for paranoia but there is a case for extreme vigilance
The FT’s senior science writer tests it out
Damage to habitats and closer contact can help multiple infections jump from wildlife
International Edition